4-borono-2-fluorophenylalanine has been researched along with phenylalanine in 29 studies
| Studies (4-borono-2-fluorophenylalanine) | Trials (4-borono-2-fluorophenylalanine) | Recent Studies (post-2010) (4-borono-2-fluorophenylalanine) | Studies (phenylalanine) | Trials (phenylalanine) | Recent Studies (post-2010) (phenylalanine) |
|---|---|---|---|---|---|
| 29 | 1 | 11 | 23,695 | 721 | 4,367 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 10 (34.48) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Hatazawa, J; Honda, C; Ichihashi, M; Ido, T; Ishiwata, K; Kubota, K; Mishima, Y; Shiono, M; Yoshino, K | 1 |
| Honda, C; Ichihashi, M; Ido, T; Ishiwata, K; Kawamura, M; Mishima, Y | 1 |
| Ichihashi, M; Ido, T; Ishiwata, K; Kawamura, M; Kubota, K; Mishima, Y | 1 |
| Ido, T; Ishiwata, K; Kubota, K; Kubota, R; Tada, M; Yamada, S | 1 |
| Hiratsuka, J; Honda, C; Ido, T; Imahori, Y; Mishima, Y; Ueda, S | 1 |
| Bailey, SF; Fuhr, JE; Kabalka, GW | 1 |
| Fujii, R; Ido, T; Imahori, Y; Kusuki, T; Ohmori, Y; Ono, K; Ueda, S | 1 |
| Fujii, R; Ido, T; Imahori, Y; Kobayashi, T; Kusuki, T; Ohmori, Y; Ono, K; Sakae, K; Takagaki, M; Ueda, S | 1 |
| Imahori, Y; Mineura, K; Takahashi, Y | 1 |
| Chang, PF; Chen, FD; Chen, JC; Deng, WP; Hwang, JJ; Lee, JS; Liao, AH; Liu, RS; Wang, HE | 1 |
| Chang, SM; Chen, JC; Hsu, FY; Liu, RS; Wang, HE | 1 |
| Imahori, Y; Mineura, K; Sasajima, H | 1 |
| Chang, CW; Chen, FD; Chen, JC; Chen, YF; Hsieh, CH; Hwang, JJ; Kai, JJ; Liu, RS; Wang, HE | 1 |
| Eskola, O; Havu-Aurén, K; Jääskeläinen, J; Kiiski, J; Kulvik, M; Lehtiö, K; Minn, H; Oikonen, V; Vähätalo, J; Vuorinen, V | 1 |
| Campanella, R; Capuani, S; D'Amore, E; Fasano, F; La Bella, A; Lecce, M; Maraviglia, B; Migneco, LM; Pastore, FS; Porcari, P | 1 |
| Inaji, M; Ishii, K; Ishiwata, K; Kimura, Y; Matsumura, A; Momose, T; Nariai, T; Ohno, K; Yamamoto, T | 1 |
| Ariyoshi, Y; Kawabata, S; Kimura, Y; Maruhashi, A; Miyatake, S; Ono, K; Shimahara, M; Suzuki, M | 1 |
| Altieri, S; Cionini, L; Menichetti, L; Minn, H; Salvadori, PA; Sauerwein, WA; Solin, O | 1 |
| Chang, CW; Chou, FI; Hsiao, MC; Hwang, JJ; Lin, YC; Wang, SJ; Yang, BH | 1 |
| Arai, Y; Fujii, H; Honda, N; Itami, J; Kawai, K; Kurihara, H; Ohe, K; Yoshimoto, M | 1 |
| Arai, Y; Hiroi, K; Honda, N; Itami, J; Kono, Y; Kumita, S; Kurihara, H; Murakami, R; Tani, H; Yoshimoto, M | 1 |
| Kuntner, C; Langer, O; Mairinger, S; Stanek, J; Wanek, T | 1 |
| Yoshimoto, M | 1 |
| Hatazawa, J; Horitsugi, G; Isohashi, K; Naka, S; Shimosegawa, E | 1 |
| Blaickner, M; Filip, T; Grunewald, C; Kudejova, P; Kuntner, C; Langer, O; Mairinger, S; Rollet, S; Sauberer, M; Schütz, C; Stanek, J; Wanek, T | 1 |
| Fujii, H; Hiroi, K; Honda, N; Itami, J; Ito, M; Kurihara, H; Nakamura, S; Shikano, N; Yoshimoto, M | 1 |
| Ishiwata, K | 1 |
| Aoki, M; Hatazawa, J; Horitsugi, G; Ikeda, H; Kanai, Y; Kongpracha, P; Nagamori, S; Naka, S; Shimosegawa, E; Watabe, T | 1 |
| Chen, YL; Chen, YW; Hu, YS; Huang, WS; Lee, JC; Li, CY; Lin, CS; Lin, KH; Lo, YW | 1 |
3 review(s) available for 4-borono-2-fluorophenylalanine and phenylalanine
| Article | Year |
|---|---|
[Molecular imaging for brain tumor using positron emission tomography].
Topics: Amino Acids; Biological Transport; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Carbon Radioisotopes; Cell Proliferation; Diglycerides; Electrons; Fluorine Radioisotopes; Humans; Neoplasm Staging; Oligodeoxyribonucleotides, Antisense; Phenylalanine; Phospholipids; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; RNA, Messenger | 2005 |
[Current Status and Prospects on PET Radiopharmaceuticals for Radiotherapy].
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Coordination Complexes; Fluorine Radioisotopes; Humans; Hypoxia; Misonidazole; Neoplasms; Nitroimidazoles; Organometallic Compounds; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones | 2015 |
4-Borono-2-
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Humans; Phenylalanine; Positron-Emission Tomography; Radiochemistry | 2019 |
1 trial(s) available for 4-borono-2-fluorophenylalanine and phenylalanine
| Article | Year |
|---|---|
Assessment of
Topics: Adult; Boron; Boron Compounds; Boron Neutron Capture Therapy; Female; Healthy Volunteers; Humans; Isotopes; Male; Middle Aged; Phenylalanine; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy, Image-Guided; Tissue Distribution; Young Adult | 2016 |
25 other study(ies) available for 4-borono-2-fluorophenylalanine and phenylalanine
| Article | Year |
|---|---|
A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
Topics: Animals; Boron Compounds; Cricetinae; Fluorine Radioisotopes; Melanoma, Experimental; Mesocricetus; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neutron Capture Therapy; Phenylalanine; Tissue Distribution; Tomography, Emission-Computed | 1992 |
4-Borono-2-[18F]fluoro-D,L-phenylalanine: a possible tracer for melanoma diagnosis with PET.
Topics: Animals; Autoradiography; Boron Compounds; Carbon Radioisotopes; Cricetinae; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Melanoma, Experimental; Mesocricetus; Mice; Neoplasm Transplantation; Phenylalanine; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Whole-Body Counting | 1992 |
4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography.
Topics: Animals; Autoradiography; Boron Compounds; Chromatography, High Pressure Liquid; Fluorine Radioisotopes; Male; Mammary Neoplasms, Experimental; Mice; Phenylalanine; Tomography, Emission-Computed | 1991 |
Cellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo.
Topics: Animals; Autoradiography; Boron Compounds; Boron Neutron Capture Therapy; Cell Division; Disease Models, Animal; DNA, Neoplasm; Fluorine Radioisotopes; Male; Melanins; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Phenylalanine; Pigmentation; Radionuclide Imaging | 1993 |
In vivo diagnosis of human malignant melanoma with positron emission tomography using specific melanoma-seeking 18F-DOPA analogue.
Topics: Boron; Boron Compounds; Brain; Brain Neoplasms; Fluorine Radioisotopes; Humans; Isotopes; Lymphatic Metastasis; Melanoma; Phenylalanine; Tomography, Emission-Computed | 1997 |
In vitro effects of boron-containing compounds upon glioblastoma cells.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA Replication; Flow Cytometry; Fluorine Radioisotopes; Fructose; Glioblastoma; Humans; Phenylalanine; Tumor Cells, Cultured | 1997 |
Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.
Topics: Astrocytoma; Boron Compounds; Brain Neoplasms; Cerebrovascular Circulation; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Phenylalanine; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Fluorine Radioisotopes; Glioma; Humans; Isotopes; Mathematical Computing; Phenylalanine; Radiation-Sensitizing Agents; Tomography, Emission-Computed | 1998 |
Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.
Topics: Adult; Aged; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Middle Aged; Phenylalanine; Prognosis; Survival Rate; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Topics: Animals; Autoradiography; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Fluorine Radioisotopes; Fructose; Glioma; Male; Phenylalanine; Rats; Rats, Inbred F344; Tissue Distribution; Tomography, Emission-Computed | 2004 |
MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma.
Topics: Animals; Boron Compounds; Brain Neoplasms; Fluorine Radioisotopes; Fructose; Glioma; Humans; Male; Phenylalanine; Positron-Emission Tomography; Rats; Rats, Inbred F344 | 2004 |
Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Topics: Animals; Blood-Brain Barrier; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Glioma; Injections, Intra-Arterial; Male; Mannitol; Metabolic Clearance Rate; Organ Specificity; Osmolar Concentration; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Distribution | 2005 |
Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
Topics: Adult; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neurilemmoma; Neurofibromatoses; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
In vivo 19F MR imaging and spectroscopy for the BNCT optimization.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line, Tumor; Fluorine; Glioma; In Vitro Techniques; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Phenylalanine; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Tissue Distribution | 2009 |
PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Topics: Algorithms; Astrocytoma; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Carbon Radioisotopes; Glioblastoma; Glioma; Humans; Methionine; Phenylalanine; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiotherapy Planning, Computer-Assisted | 2009 |
Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node.
Topics: Adult; Aged; Aged, 80 and over; Boron Compounds; Boron Neutron Capture Therapy; Female; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Recurrence, Local; Pain; Phenylalanine; Positron-Emission Tomography; Quality of Life; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Fluorine Radioisotopes; Humans; Isotopes; Lymphatic Metastasis; Melanoma; Models, Biological; Neoplasms; Phenylalanine; Positron-Emission Tomography; Prognosis; Radiation-Sensitizing Agents; Tomography, X-Ray Computed | 2009 |
Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Fluorine Radioisotopes; Fructose; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Phenylalanine; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2012 |
Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells.
Topics: Amino Acid Transport Systems; Biological Transport; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Methionine; Phenylalanine; Positron-Emission Tomography | 2013 |
Correlation of (18)F-BPA and (18)F-FDG uptake in head and neck cancers.
Topics: Adult; Aged; Boron Compounds; Boron Neutron Capture Therapy; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Automated electrophilic radiosynthesis of [¹⁸F]FBPA using a modified nucleophilic GE TRACERlab FXFDG.
Topics: Boron Compounds; Electron Transport; Electrons; Equipment Design; Equipment Failure Analysis; Fluorine Radioisotopes; Isotope Labeling; Materials Testing; Phenylalanine; Radiopharmaceuticals; Robotics | 2015 |
On the applicability of [
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Female; Humans; Liver Neoplasms; Mice; Phenylalanine; Positron-Emission Tomography | 2017 |
Non-invasive estimation of
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Female; Humans; Infusions, Intravenous; Mice; Mice, Inbred BALB C; Phenylalanine; Positron-Emission Tomography; Tissue Distribution | 2018 |
Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
Topics: Animals; Blood Circulation; Boron Compounds; Cell Line, Tumor; Cell Transformation, Neoplastic; Glioma; Humans; Large Neutral Amino Acid-Transporter 1; Male; Pancreatic Neoplasms; Phenylalanine; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Rats; Tissue Distribution; Tyrosine | 2019 |
The importance of optimal ROIs delineation for FBPA-PET before BNCT.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Feasibility Studies; Humans; Phenylalanine; Positron-Emission Tomography | 2020 |